 MIAMI, Nov. 29, 2022 GLOBE NEWSWIRE -- Longeveron Inc. NASDAQ: LGVN Longeveron or Company, a clinical stage biotechnology company developing regenerative medicines for unmet medical needs, today announced that Company leadership will participate in three upcoming investor conferences. 